Allan Jonathan
SEC insider (Form 3/4/5 filer). CIK 0001966716. GENERAL COUNSEL & CORP SEC at Stoke Therapeutics, Inc. (STOK). 53 reported Form 4/5 transactions since Sep 2024; latest on Oct 2, 2026. Located in BEDFORD, MA.
Companies Allan Jonathan has filed insider reports for
- Stoke Therapeutics, Inc. (STOK): Officer, GENERAL COUNSEL & CORP SEC
Allan Jonathan
CIK: 0001966716
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Stoke Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (53 total)
- Oct 2, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect627 shares at avg. $26.33$17K - Aug 18, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect145 shares at avg. $32.47$5K - Aug 18, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect2.7K shares at avg. $32.01$87K - Aug 14, 2026STOK
Stoke Therapeutics, Inc.
ExerciseDirect6K shares- - Jun 16, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect1.5K shares at avg. $29.95$44K - Mar 20, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect8.7K shares at avg. $33.64$292K - Mar 20, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect601 shares at avg. $34.41$21K - Mar 18, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect4.2K shares at avg. $31.28$132K - Mar 18, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect72 shares at avg. $32.85$2K - Mar 18, 2026STOK
Stoke Therapeutics, Inc.
SaleDirect334 shares at avg. $31.79$11K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 2, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 627 | $26.33 | $16,509 | Direct |
| Aug 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 145 | $32.47 | $4,708 | Direct |
| Aug 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 2,716 | $32.01 | $86,932 | Direct |
| Aug 14, 2026 | STOK Stoke Therapeutics, Inc. | Exercise | 6,000 | - | $0 | Direct |
| Jun 16, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 1,457 | $29.95 | $43,637 | Direct |
| Mar 20, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 8,692 | $33.64 | $292,359 | Direct |
| Mar 20, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 601 | $34.41 | $20,679 | Direct |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 4,222 | $31.28 | $132,080 | Direct |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 72 | $32.85 | $2,365 | Direct |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale | 334 | $31.79 | $10,617 | Direct |
1-10 of 53 transactions